“Feasibility Study for the Development of Combination Dosage Form Containing Aspirin and Omeprazole for Treating Cardiovascular and Cerebrovascular Events” (2025) Bangladesh Pharmaceutical Journal, 28(1), pp. 105–113. doi:10.3329/bpj.v28i1.79470.